Business
Currency:USD
2025/Q1
Stock NameRevenueRatio
Minimal Residual Disease (MRD)43.72M83.37%
Immune Medicine8.72M16.63%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States178.96M100.00%